Last checked at 17 Jan 2018 15:25
The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.
17 January 2018
Accrol Group Holdings plc
(the "Company")
Update on Health and Safety Incident
Further to the Update on Health & Safety Incident announcement made by Accrol Group Holdings plc (AIM:ACRL) on 12 October 2017, the Company announces that, at the sentencing hearing today, Accrol Papers Limited (a directly owned subsidiary of the Company) was fined £120,000 (after discount) for a single health and safety regulatory offence.
The sentencing court commented that the fine had been reduced by one third in light of the guilty plea entered at the earliest opportunity and the Company's full co-operation with the HSE investigation. The Company has been given 12 months to pay the fine.
As previously reported, the Health & Safety Executive (HSE) had previously indicated to the Company that it was seeking a fine in the range of £550,000 to £2.9m for this incident.
Accrol takes the Health and Safety of its employees very seriously and the directors are pleased that this has been recognised in today's judgement.
For further information, please contact: |
|
|
|
Accrol Group Holdings plc | Tel: +44 (0) 1254 278844 |
Gareth Jenkins, Chief Executive Officer |
|
|
|
Zeus Capital Limited (Nominated Adviser & Broker) |
|
Dan Bate / Andrew Jones | Tel: +44 (0) 161 831 1512 |
Dominic King / John Goold | Tel: +44 (0) 203 829 5000 |
Belvedere Communications Limited | Tel: +44 (0) 20 3567 0510 |
Cat Valentine | cvalentine@belvederepr.com |
John West | jwest@belvederepr.com |
Kim Van Beeck | kvbeeck@belvederepr.com |
Notes to Editors
Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues as well as other tissue products to the UK's largest retailers.
Accrol operates from three sites:
· a manufacturing, storage and distribution facility in Blackburn;
· a facial tissue plant, also in Blackburn; and
· a manufacturing, storage and distribution facility in Leyland.
In addition, the business has a 368,000 sq ft storage and distribution facility in Skelmersdale, Lancashire.
Accrol manufactures approximately 18 million units per week, supplying customers with both Accrol branded and "private label" products.